Member Info for Asleep

Sounds just like a UK weather forecast!

I think it is significant that Eli Lilly were happy to be revealed recently from the 'GlobalCo' name. It has also been a little while since the last rns news with the Penn calaboration. So therefore I am expecting news anytime however am happy to wait based on the strong pipeline of projects Hemo have in place.

I've been asleep and cannot see the edge up. I can see a lot of edge down in the last few days so hoping for a leap up or I might have to buy some more to add to my overweight position.

Say no more.

Are you looking down your trousers!

My margin of safety is taking a hammering.

For impending positive news I am surprised that Hemo is down again today.

Lots of work going on with Eli LIlly, working closely together, all positive......
While the agreement stipulates certain confidential provisions, including the pharmaceutical company's identity at this stage, Hemogenyx has disclosed that GlobalCo is the same organisation with which it is collaborating to develop its CDX antibody product candidate.

In addition, the group has a research agreement with GlobalCo for the development of its ‘humanised mice’ which have been developed for previous research to focus on coronavirus antibodies.

“This close collaboration offers the potential for ongoing value-adding licensing arrangements with a major pharmaceutical company with the benefit of their global reach and large-scale resources,” added Sandler.?

Hemogenyx added that it is also in preliminary discussions with a global biopharmaceutical firm "regarding a potential licensing deal" for the CDX antibodies are continuing.

Executive Chair Marc Feldmann said: "The board is very pleased with the progress being made with the unlocking of additional opportunities for the CDX antibodies, as well as the potential value that can be created through the company's updated humanised mouse model.

"The board believes that the company is well advanced on the planned development steps for its CDX antibodies that were announced at admission, and we hope to provide further updates to shareholders as we progress. The company looks forward to the future with confidence."

Time is ticking by, multiple overdue RNS announcements will show ducks lined up. I won't be selling on the first spike, looking for multiple spikes towards £3+ a share, hold tight for the ride up.

Hemo have been flexible with the 3 month extenstion with Eli Lilly now they need to crack on and sign or do one.

I love this sentence from Vlad in the RNS of 13th July 2020 -
This close collaboration (with Eli Lilly) offers the potential for ongoing value-adding licensing arrangements with a major pharmaceutical company (Eli Lilly) with the benefit of their global reach and large-scale resources."

There is no need to feel sorry for those buying at 15p, its a good move because they can sell when Hemo is much higher.

Personally, I like the positive comments from Vlad about the working relationship he has with Eli Lilly and the culture similarities. The name reveal recently from (globalco) I think was meaningful. The share options at 7p. The change of name etc etc.. Ducks lining up in my opinion, so I believe the license will come before xmas, maybe next week or today. I'm holding no more spare cash to invest.

As far as I believe the 3 month extension ends on 2nd September, this is why the share prices has risen in the last few days, because news could fall at any time.

On ii investing it took 3 full days to 'bed & isa' my hemo shares and I ended up worse off with higher average share price and a lower amount of shares! Live and learn I should have done it sooner.

The longer we don't have news during the next few days the more the price will tick up. All good.

why is my ii investing always behind the google price.

11p on no news. Positive cdx news 35p plus.

£300-400m